{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:44:58Z","timestamp":1763729098832,"version":"3.45.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:00:00Z","timestamp":1740268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:00:00Z","timestamp":1740268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11030-025-11134-5","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T12:35:26Z","timestamp":1740314126000},"page":"6227-6241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design, synthesis and biological evaluation of novel dualaction\nstatin conjugates with triglyceride and cholesterol lowering activities"],"prefix":"10.1007","volume":"29","author":[{"given":"Zheng","family":"Qu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye-Cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Suo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan-Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,23]]},"reference":[{"key":"11134_CR1","doi-asserted-by":"publisher","first-page":"132717","DOI":"10.1016\/j.tet.2022.132717","volume":"111","author":"N Vempala","year":"2022","unstructured":"Vempala N, Matta B, Rao SV et al (2022) An efficient, cyanide free total synthesis of rosuvastatin calcium. Tetrahedron 111:132717. https:\/\/doi.org\/10.1016\/j.tet.2022.132717","journal-title":"Tetrahedron"},{"issue":"5","key":"11134_CR2","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.apsb.2020.11.001","volume":"11","author":"G Luo","year":"2021","unstructured":"Luo G, Li Z, Lin X et al (2021) Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivo. Acta Pharmaceutica Sinica B 11(5):1300\u20131314. https:\/\/doi.org\/10.1016\/j.apsb.2020.11.001","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"1","key":"11134_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","volume":"161","author":"JL Goldstein","year":"2015","unstructured":"Goldstein JL, Brown MS (2015) A century of cholesterol and coronaries: from plaques to genes to statins. Cell 161(1):161\u2013172. https:\/\/doi.org\/10.1016\/j.cell.2015.01.036","journal-title":"Cell"},{"issue":"5519","key":"11134_CR4","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.1059344","volume":"292","author":"ES Istvan","year":"2001","unstructured":"Istvan ES, Deisenhofer J (2001) Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292(5519):1160\u20131164. https:\/\/doi.org\/10.1126\/science.1059344","journal-title":"Science"},{"issue":"6","key":"11134_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1753-4887.2012.00479.x","volume":"70","author":"MK Douglas","year":"2012","unstructured":"Douglas MK, John H, Erminia G (2012) Niacin: chemical forms, bioavailability, and health effects. Nutr Rev 70(6):357\u2013366. https:\/\/doi.org\/10.1111\/j.1753-4887.2012.00479.x","journal-title":"Nutr Rev"},{"issue":"4","key":"11134_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1021\/acsmedchemlett.8b00574","volume":"10","author":"L Giampietro","year":"2019","unstructured":"Giampietro L, Laghezza A, Cerchia C et al (2019) Novel phenyldiazenyl fibrate analogues as PPAR \u03b1\/\u03b3\/\u03b4 pan-agonists for the amelioration of metabolic syndrome. ACS Med Chem Lett 10(4):545\u2013551. https:\/\/doi.org\/10.1021\/acsmedchemlett.8b00574","journal-title":"ACS Med Chem Lett"},{"key":"11134_CR7","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/s0140-6736(10)60284-x","volume":"357","author":"FJ Raal","year":"2010","unstructured":"Raal FJ, Santos RD, Blom DJ et al (2010) Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial. Lancet 357:998\u20131006. https:\/\/doi.org\/10.1016\/s0140-6736(10)60284-x","journal-title":"Lancet"},{"issue":"16","key":"11134_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.11569\/wcjd.v31.i16.659","volume":"31","author":"XH Fang","year":"2023","unstructured":"Fang XH, Wang C, Deng J et al (2023) Advances in statin therapy for fatty liver disease. World Chinese J Dig 31(16):659\u2013665","journal-title":"World Chinese J Dig"},{"issue":"21","key":"11134_CR9","doi-asserted-by":"publisher","first-page":"882","DOI":"10.11569\/wcjd.v31.i21.882","volume":"31","author":"HM Chen","year":"2023","unstructured":"Chen HM, Su DS, Li HY et al (2023) Progress in lipid-lowering therapy for hypertriglyceridemic acute pancreatitis. World Chinese J Dig 31(21):882\u2013888","journal-title":"World Chinese J Dig"},{"key":"11134_CR10","doi-asserted-by":"publisher","first-page":"13207","DOI":"10.12677\/ACM.2023.1381845","volume":"13","author":"H Yu","year":"2023","unstructured":"Yu H, Liu Y, Wang YN et al (2023) Advances in statins in reducing residual cholesterol. Adv Clin Med 13:13207","journal-title":"Adv Clin Med"},{"key":"11134_CR11","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ijcard.2016.06.234","volume":"221","author":"S Zhao","year":"2016","unstructured":"Zhao S, Wang F, Dai Y et al (2016) Efficacy and safety of fenofibrate as an add-on in patients with elevated triglyceride despite receiving statin treatment. Int J Cardiol 221:832\u2013836. https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.234","journal-title":"Int J Cardiol"},{"issue":"2","key":"11134_CR12","first-page":"17","volume":"2","author":"Y Li","year":"2012","unstructured":"Li Y, Chen FR, Huang JW (2012) Efficacy of simvastatin combined with fenofibrate in the treatment of mixed hyperlipidemia. Chin Med Sci J 2(2):17\u201319","journal-title":"Chin Med Sci J"},{"issue":"15","key":"11134_CR13","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1161\/01.cir.0000034044.95911.dc","volume":"106","author":"T Sudhop","year":"2002","unstructured":"Sudhop T, Ldtjohann D, Kodal A et al (2002) Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 106(15):1943\u20131948. https:\/\/doi.org\/10.1161\/01.cir.0000034044.95911.dc","journal-title":"Circulation"},{"issue":"9","key":"11134_CR14","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/j.1463-1326.2009.01061.x","volume":"11","author":"JE Tomassini","year":"2009","unstructured":"Tomassini JE, Mazzone T, Goldberg RB et al (2009) Effect of ezetimibe\/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia. Diabetes Obes Metab 11(9):855\u2013864. https:\/\/doi.org\/10.1111\/j.1463-1326.2009.01061.x","journal-title":"Diabetes Obes Metab"},{"issue":"04","key":"11134_CR15","first-page":"280","volume":"48","author":"ZY Yuan","year":"2020","unstructured":"Yuan ZY, Han YL (2020) Chinese expert consensus on lipid management of very high-risk atherosclerotic cardiovascular disease patients. Chin J Cardiol 48(04):280\u2013286","journal-title":"Chin J Cardiol"},{"issue":"10","key":"11134_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.5414\/cp203374","volume":"57","author":"D Ha","year":"2019","unstructured":"Ha D, Yeon-Ju L, Chun Y et al (2019) Comparison of signal detection between statin and statin\/ezetimibe fixed-dose combination using the Korea adverse events reporting system database, 2005\u20132016. Int J Clin Pharmacol Ther 57(10):489. https:\/\/doi.org\/10.5414\/cp203374","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"11134_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/molecules21010042","volume":"21","author":"DH Jornada","year":"2015","unstructured":"Jornada DH, Fernandes GF, Chiba DE et al (2015) The prodrug approach: a successful tool for improving drug solubility. Molecules 21(1):42. https:\/\/doi.org\/10.3390\/molecules21010042","journal-title":"Molecules"},{"key":"11134_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/128_2010_76","volume":"299","author":"H Fujii","year":"2011","unstructured":"Fujii H (2011) Twin and triplet drugs in opioid research. Top Curr Chem 299:239\u2013275. https:\/\/doi.org\/10.1007\/128_2010_76","journal-title":"Top Curr Chem"},{"key":"11134_CR19","doi-asserted-by":"publisher","DOI":"10.13557\/j.cnki.issn1002-2813.2022.03.027","author":"F Long","year":"2022","unstructured":"Long F, Qu MR, Zou BC et al (2022) Effect of niacin on lipid metabolism and its mechanism. Feed Res. https:\/\/doi.org\/10.13557\/j.cnki.issn1002-2813.2022.03.027","journal-title":"Feed Res"},{"issue":"12","key":"11134_CR20","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.13241\/j.cnki.pmb.2017.12.024","volume":"17","author":"H Du","year":"2017","unstructured":"Du H, Zhang WW, Niu JY et al (2017) Effect of ligustrazine injection on clinical symptoms and hemorheology in patients with angina pectoris of coronary heart disease. Adv Modern Biomed 17(12):2298\u20132301. https:\/\/doi.org\/10.13241\/j.cnki.pmb.2017.12.024","journal-title":"Adv Modern Biomed"},{"key":"11134_CR21","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.3390\/molecules23102540","volume":"23","author":"W Wu","year":"2018","unstructured":"Wu W, Liang X, Xie G et al (2018) Synthesis and evaluation of novel ligustrazine derivatives as multi-targeted inhibitors for the treatment of Alzheimer\u2019s disease. Molecules 23:2540. https:\/\/doi.org\/10.3390\/molecules23102540","journal-title":"Molecules"},{"key":"11134_CR22","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1016\/j.bmc.2016.08.060","volume":"24","author":"YX Sun","year":"2016","unstructured":"Sun YX, Zhang YS, Li YY et al (2016) Synthesis and biological evaluation of novel hydrogen sulfide releasing nicotinic acid derivatives. Bioorg Med Chem 24:5368\u20135373. https:\/\/doi.org\/10.1016\/j.bmc.2016.08.060","journal-title":"Bioorg Med Chem"},{"key":"11134_CR23","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/ph15020198","volume":"15","author":"S Yigitkan","year":"2022","unstructured":"Yigitkan S, Ertas A, Salmas RE et al (2022) 7-Acetoxyhorminone from Salvia multicaulis Vahl. as promising inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase. Pharmaceuticals 15:198. https:\/\/doi.org\/10.3390\/ph15020198","journal-title":"Pharmaceuticals"},{"key":"11134_CR24","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1021\/acs.jnatprod.5b00331","volume":"78","author":"K Wang","year":"2015","unstructured":"Wang K, Bao L, Xiong W et al (2015) Lanostane triterpenes from the Tibetan medicinal mushroom Ganoderma leucocontextum and their inhibitory effects on HMG-CoA reductase and \u03b1-glucosidase. J Nat Prod 78:1977\u20131989. https:\/\/doi.org\/10.1021\/acs.jnatprod.5b00331","journal-title":"J Nat Prod"},{"key":"11134_CR25","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1007\/s00044-024-03247-7","volume":"33","author":"BO Alomari","year":"2024","unstructured":"Alomari BO, Fakhouri LI, Al-Shari NA et al (2024) Design, synthesis and biological evaluation of potent thiazolidinedione salicylic acid inhibitors against glyoxalase-I as potential anticancer agents. Med Chem Res 33:1526\u20131540. https:\/\/doi.org\/10.1007\/s00044-024-03247-7","journal-title":"Med Chem Res"},{"issue":"W1","key":"11134_CR26","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong G, Wu Z, Yi J et al (2021) ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res 49(W1):W5\u2013W14. https:\/\/doi.org\/10.1093\/nar\/gkab255","journal-title":"Nucleic Acids Res"},{"key":"11134_CR27","doi-asserted-by":"publisher","first-page":"721","DOI":"10.19405\/j.cnki.issn1000-1492.2014.06.005","volume":"49","author":"XR Shen","year":"2014","unstructured":"Shen XR, Lu YX, Zhang Q et al (2014) Mechanism of action of fenofibrate in protecting insulin resistance in mice with nonalcoholic fatty liver disease. J Anhui Med Univ 49:721\u2013725. https:\/\/doi.org\/10.19405\/j.cnki.issn1000-1492.2014.06.005","journal-title":"J Anhui Med Univ"},{"key":"11134_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1021\/jm070849r","volume":"51","author":"JA Pfefferkorn","year":"2008","unstructured":"Pfefferkorn JA, Choi C, Larsen SD et al (2008) Substituted pyrazoles as hepatoselective HMG-CoA reductase inhibitors: discovery of (3R,5R)-7-[2-(4-Fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylcarbamoyl)-2H-pyrazol-3-yl]-3,5-dihydroxyheptanoic acid (PF-3052334) as a candidate for the treatment of hypercholesterolemia. J Med Chem 51:31\u201345. https:\/\/doi.org\/10.1021\/jm070849r","journal-title":"J Med Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11134-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11134-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11134-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:28:52Z","timestamp":1763728132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11134-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,23]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11134"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11134-5","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"type":"print","value":"1381-1991"},{"type":"electronic","value":"1573-501X"}],"subject":[],"published":{"date-parts":[[2025,2,23]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal procedures were conducted in accordance with the relevant guidelines for the care and use of laboratory animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}